ZYUS Life Sciences Corporation

C$0.32As of Sun 8 Nov 2026, 12:00 UTC
TSXV:ZYUSHealthcare
Country Canada
PE (Fwd) •••
TSR 3Y CAGR (31.98%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM —
TSR TTM (52.94%)
Mkt cap C$25.77M
ROIC (15280.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.406
26.85%
(34.27%)
Buy 11|5|1|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
5.94%
(6.87%)
(7.86%)
(6.37%)
Revenue$M
1.705
1.781
1.819
1.841
(3.50%)
0.74%
3.56%
5.44%
Peers (US$18.24M)
Cap (US$)
PE
15.00M
4.459x
18.13M
1.110x
Capital
TTM
5Y
10Y
Leveragex
0.064
0.106
0.098
EBIT/Intx
0.586
0.705
0.596
Own earn%
75.44
103.96
100.77
Sh yield%
48.73
18.41
21.45
Owners
Insiders/Inst%
9.46
44.65
Short interest%
5.53
SBC / revenue%
4.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
13–23
$1 testx
−0.8
Incr. ROIC%
2